Ajuste direto para aquisição de A53311- Acalabrutinib [100 mg; cáp/comp]

ID 11928172 · Portal BASE
Price
Base Price
€1,260,138 .00
Effective Price
€67,886 .00 -94.6%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Porto, Porto
Bidder Count
—
Winner
ASTRAZENECA - PRODUTOS FARMACÊUTICOS LDA
NIF 502942240
Company
Dates
Publication
12 Nov 2025
Celebration
25 Feb 2025
Contracting Entity
Unidade Local de Saúde de Santo António, EPE
NIF 517392259
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 100 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
745
Supplier
45
Number of Awards
14
Rule
A1 repeat direct award: 14 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
12 Nov 2025
Signing Date
25 Feb 2025
Days Late
260
Rule
A2/A3 late publication: 260 days after signing (threshold: 10)
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
1260138.0
Total effective price
67886.0
Ratio
0.0539
Direction
reduction
Rule
A9 price reduction: ratio 0.0539 outside [0.5, 1.5]
Detected 2026-03-06